Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 11Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1IOL Chemicals and Pharmaceuticals Ltd.

02 3Granules India Limited

03 1Adare Pharmaceuticals, Inc.

04 1Asclemed USA Inc.

05 5BASF Corporation

06 1BASF SE

07 1Fagron Inc

08 1Fagron Services B.V.

09 2Hubei Biocause Heilen Pharmaceutical Co., Ltd

10 1L.N.K. International, Inc.

11 1LETCO MEDICAL, LLC

12 1Medisca Inc.

13 1Particle Dynamics International, LLC

14 2Professional Compounding Centers of America

15 1Professional Compounding Centers of America dba PCCA

16 2SMS Pharmaceuticals Limited

17 1SOLARA ACTIVE PHARMA SCIENCES LIMITED

18 2Shandong Xinhua Pharmaceutical Company Limited

19 2SpecGx LLC

20 1Spectrum Laboratory Products, Inc.

21 2Zibo Xinhua - Perrigo Pharmaceutical Co., Ltd

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
PharmaVenue
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothIOL Chemicals is an innovation-driven bulk drug, Intermediate and Specialty Chemicals company.

IBUPROFEN

NDC Package Code : 49716-325

Start Marketing Date : 2017-06-15

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

IOL Chemicals

02

arrow
PharmaVenue
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothGranules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

IBUPROFEN

NDC Package Code : 62207-300

Start Marketing Date : 2011-02-16

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (66mg/100mg)

Marketing Category : DRUG FOR FURTHER PROCESSING

Granules India

03

arrow
PharmaVenue
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothGranules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

IBUPROFEN

NDC Package Code : 62207-303

Start Marketing Date : 2019-11-01

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (85mg/100mg)

Marketing Category : DRUG FOR FURTHER PROCESSING

Granules India

04

arrow
PharmaVenue
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothGranules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

IBUPROFEN

NDC Package Code : 62207-311

Start Marketing Date : 2015-09-14

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (66mg/100mg)

Marketing Category : DRUG FOR FURTHER PROCESSING

Granules India

05

PharmaVenue
Not Confirmed
arrow
arrow
PharmaVenue
Not Confirmed

IBUPROFEN

NDC Package Code : 10117-0926

Start Marketing Date : 2010-06-08

End Marketing Date : 2024-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

06

PharmaVenue
Not Confirmed
arrow
arrow
PharmaVenue
Not Confirmed

IBUPROFEN

NDC Package Code : 10117-0930

Start Marketing Date : 2010-06-08

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT FOR HUMAN P...

blank

07

PharmaVenue
Not Confirmed
arrow
arrow
PharmaVenue
Not Confirmed

IBUPROFEN

NDC Package Code : 10117-0931

Start Marketing Date : 2014-01-02

End Marketing Date : 2024-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

08

PharmaVenue
Not Confirmed
arrow
arrow
PharmaVenue
Not Confirmed

IBUPROFEN

NDC Package Code : 10117-0936

Start Marketing Date : 2010-06-08

End Marketing Date : 2024-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT FOR HUMAN P...

blank

09

PharmaVenue
Not Confirmed
arrow
arrow
PharmaVenue
Not Confirmed

IBUPROFEN

NDC Package Code : 0406-3823

Start Marketing Date : 2013-02-08

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (0.63kg/kg)

Marketing Category : DRUG FOR FURTHER PROCESSING

blank

10

PharmaVenue
Not Confirmed
arrow
arrow
PharmaVenue
Not Confirmed

IBUPROFEN

NDC Package Code : 0406-3825

Start Marketing Date : 2013-02-08

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (0.9kg/kg)

Marketing Category : DRUG FOR FURTHER PROCESSING

blank

(?)-Ibuprofen Manufacturers

A (?)-Ibuprofen manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of (?)-Ibuprofen, including repackagers and relabelers. The FDA regulates (?)-Ibuprofen manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. (?)-Ibuprofen API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of (?)-Ibuprofen manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

(?)-Ibuprofen Suppliers

A (?)-Ibuprofen supplier is an individual or a company that provides (?)-Ibuprofen active pharmaceutical ingredient (API) or (?)-Ibuprofen finished formulations upon request. The (?)-Ibuprofen suppliers may include (?)-Ibuprofen API manufacturers, exporters, distributors and traders.

click here to find a list of (?)-Ibuprofen suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

(?)-Ibuprofen NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing (?)-Ibuprofen as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for (?)-Ibuprofen API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture (?)-Ibuprofen as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain (?)-Ibuprofen and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a (?)-Ibuprofen NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of (?)-Ibuprofen suppliers with NDC on PharmaCompass.

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.